Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Joseph J Larosa. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Joseph J Larosa har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:REGN / Regeneron Pharmaceuticals, Inc. EVP General Counsel and Secret 29.517
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Joseph J Larosa. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Joseph J Larosa som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2025-12-09 2025-12-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -1.396 29.517 -4,52 712,94 -995.264 21.043.850
2025-12-09 2025-12-05 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
A - Award 2.476 30.913 8,71
2025-11-24 2025-11-20 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -12.686 22.839 -35,71 736,77 -9.346.664 16.827.090
2025-11-24 2025-11-20 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 14.450 35.525 68,56 555,67 8.029.432 19.740.177
2024-12-18 2024-12-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -702 30.075 -2,28 730,81 -513.029 21.979.111
2024-12-10 2024-12-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -492 30.777 -1,57 787,00 -387.204 24.221.499
2024-12-10 2024-12-06 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
A - Award 2.332 31.269 8,06
2024-07-12 2024-07-11 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1.866 37.937 -4,69 1.088,95 -2.031.981 41.311.496
2024-06-25 2024-06-24 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -11.084 39.803 -21,78 1.060,13 -11.750.481 42.196.354
2024-06-25 2024-06-24 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 14.450 50.887 39,66 555,67 8.029.432 28.276.379
2024-06-12 2024-06-10 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
G - Gift -1.608 0 -100,00
2024-05-22 2024-05-21 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1.865 34.678 -5,10 994,90 -1.855.488 34.501.142
2024-02-28 2024-02-26 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale -1.000 36.543 -2,66 990,00 -990.000 36.177.570
2024-02-26 2024-02-22 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale -1.000 37.543 -2,59 967,65 -967.650 36.328.484
2024-02-09 2024-02-07 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale -1.000 38.543 -2,53 950,00 -950.000 36.615.850
2024-01-04 2024-01-03 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -24.493 39.543 -38,25 912,30 -22.344.964 36.075.079
2024-01-04 2024-01-03 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 34.000 64.036 113,20 399,66 13.588.440 25.592.628
2023-12-12 2023-12-11 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -669 30.036 -2,18 844,09 -564.696 25.353.087
2023-12-12 2023-12-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
A - Award 2.133 30.705 7,47
2023-12-12 2023-12-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -852 28.572 -2,90 843,79 -718.909 24.108.768
2023-03-27 2023-03-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -6.742 27.471 -19,71 801,59 -5.404.320 22.020.479
2023-03-27 2023-03-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 10.000 34.213 41,30 270,43 2.704.300 9.252.222
2023-03-14 2023-03-10 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
G - Gift -1.006 0 -100,00
2022-12-20 2022-12-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
A - Award 2.752 23.110 13,52
2022-12-13 2022-12-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -492 20.358 -2,36 753,28 -370.614 15.335.274
2022-09-12 2022-09-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -20.730 20.850 -49,86 730,96 -15.152.801 15.240.516
2022-09-12 2022-09-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 30.000 41.580 259,07 270,43 8.112.900 11.244.479
2022-04-11 2022-04-07 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -5.114 16.900 -23,23 721,10 -3.687.705 12.186.590
2022-04-04 2022-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -15 22.014 -0,07 701,82 -10.527 15.449.865
2022-04-04 2022-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -124 22.029 -0,56 698,26 -86.584 15.381.970
2022-04-04 2022-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -64 22.153 -0,29 697,35 -44.630 15.448.395
2022-04-04 2022-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -254 22.217 -1,13 696,54 -176.921 15.475.029
2022-04-04 2022-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -305 22.471 -1,34 695,36 -212.085 15.625.435
2022-04-04 2022-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -259 22.776 -1,12 694,56 -179.891 15.819.299
2022-04-04 2022-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -567 23.035 -2,40 693,92 -393.453 15.984.447
2022-04-04 2022-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -195 23.602 -0,82 692,54 -135.045 16.345.329
2022-04-04 2022-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -641 23.797 -2,62 691,44 -443.213 16.454.198
2022-04-04 2022-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -250 24.438 -1,01 690,51 -172.628 16.874.683
2022-04-04 2022-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -218 24.688 -0,88 689,43 -150.296 17.020.648
2022-04-04 2022-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -799 24.906 -3,11 688,59 -550.183 17.150.023
2022-04-04 2022-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -497 25.705 -1,90 687,41 -341.643 17.669.874
2022-04-04 2022-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -557 26.202 -2,08 686,26 -382.247 17.981.385
2022-04-04 2022-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -369 26.759 -1,36 685,71 -253.027 18.348.914
2021-12-14 2021-12-11 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -697 26.051 -2,61 664,34 -463.045 17.306.721
2021-12-10 2021-12-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
M - Exercise -30.000 0 -100,00
2021-12-10 2021-12-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -19.772 26.748 -42,50 657,11 -12.992.379 17.576.378
2021-12-10 2021-12-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 30.000 46.520 181,60 179,13 5.373.900 8.333.128
2021-12-10 2021-12-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
A - Award 14.253 14.253
2021-12-10 2021-12-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
A - Award 3.338 16.520 25,32
2021-08-24 2021-08-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1 13.182 -0,01 666,22 -666 8.782.112
2021-08-24 2021-08-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -41 13.183 -0,31 665,40 -27.281 8.771.968
2021-08-24 2021-08-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -3.383 13.224 -20,37 661,80 -2.238.869 8.751.643
2021-08-24 2021-08-20 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
M - Exercise X -10.000 30.000 -25,00
2021-08-24 2021-08-20 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes X -6.575 16.607 -28,36 664,85 -4.371.389 11.041.164
2021-08-24 2021-08-20 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 10.000 23.182 75,86 179,13 1.791.300 4.152.592
2021-07-07 2021-07-06 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -3.398 13.182 -20,49 580,00 -1.970.840 7.645.560
2021-07-07 2021-07-02 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
M - Exercise X -10.000 40.000 -20,00
2021-07-07 2021-07-02 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes X -6.602 16.580 -28,48 582,20 -3.843.684 9.652.876
2021-07-07 2021-07-02 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 10.000 23.182 75,86 179,13 1.791.300 4.152.592
2020-12-11 2020-12-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
A - Award 19.950 19.950
2020-12-11 2020-12-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
A - Award 1.930 16.368 13,37
2020-08-31 2020-08-31 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale -4.672 14.438 -24,45 615,04 -2.873.467 8.879.948
2020-08-31 2020-08-27 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
M - Exercise -4.000 0 -100,00
2020-08-31 2020-08-27 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
M - Exercise -6.000 4.000 -60,00
2020-08-31 2020-08-27 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -2.131 19.110 -10,03 614,87 -1.310.288 11.750.166
2020-08-31 2020-08-27 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 4.000 21.241 23,20 52,03 208.120 1.105.169
2020-08-31 2020-08-27 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -3.197 17.241 -15,64 614,87 -1.965.739 10.600.974
2020-08-31 2020-08-27 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 6.000 20.438 41,56 52,03 312.180 1.063.389
2020-05-15 2020-05-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -8.380 14.438 -36,73 572,00 -4.793.360 8.258.536
2020-05-15 2020-05-14 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
M - Exercise X -18.311 0 -100,00
2020-05-15 2020-05-14 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes X -9.931 22.818 -30,32 573,18 -5.692.251 13.078.821
2020-05-15 2020-05-14 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 18.311 32.749 126,83 59,20 1.084.011 1.938.741
2020-04-20 2020-04-20 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -577 14.438 -3,84 573,59 -330.961 8.281.492
2020-04-20 2020-04-20 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -61 15.015 -0,40 572,94 -34.949 8.602.694
2020-04-20 2020-04-20 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -112 15.076 -0,74 571,65 -64.025 8.618.195
2020-04-20 2020-04-20 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -125 15.188 -0,82 570,27 -71.284 8.661.261
2020-04-20 2020-04-20 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -234 15.313 -1,51 569,41 -133.242 8.719.375
2020-04-20 2020-04-20 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -669 15.547 -4,13 567,30 -379.524 8.819.813
2020-04-20 2020-04-17 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
M - Exercise X -5.000 18.311 -21,45
2020-04-20 2020-04-17 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
M - Exercise X -6.622 23.311 -22,12
2020-04-20 2020-04-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
M - Exercise X -5.000 29.933 -14,31
2020-04-20 2020-04-20 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1.189 16.216 -6,83 566,44 -673.497 9.185.391
2020-04-20 2020-04-20 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1.468 17.405 -7,78 565,60 -830.301 9.844.268
2020-04-20 2020-04-20 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -377 18.873 -1,96 564,74 -212.907 10.658.338
2020-04-20 2020-04-20 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -416 19.250 -2,12 563,58 -234.449 10.848.915
2020-04-20 2020-04-20 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -21 19.666 -0,11 562,71 -11.817 11.066.255
2020-04-20 2020-04-20 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -51 19.687 -0,26 561,57 -28.640 11.055.629
2020-04-20 2020-04-17 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes X -2.720 19.738 -12,11 555,82 -1.511.830 10.970.775
2020-04-20 2020-04-17 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 5.000 22.458 28,64 59,20 296.000 1.329.514
2020-04-20 2020-04-17 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes X -3.602 17.458 -17,10 555,82 -2.002.064 9.703.506
2020-04-20 2020-04-17 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 6.622 21.060 45,87 59,20 392.022 1.246.752
2020-04-20 2020-04-17 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -94 14.438 -0,65 565,92 -53.196 8.170.753
2020-04-20 2020-04-17 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -93 14.532 -0,64 564,19 -52.470 8.198.809
2020-04-20 2020-04-17 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -171 14.625 -1,16 563,39 -96.340 8.239.579
2020-04-20 2020-04-17 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -191 14.796 -1,27 562,56 -107.449 8.323.638
2020-04-20 2020-04-17 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -63 14.987 -0,42 561,76 -35.391 8.419.097
2020-04-20 2020-04-17 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -163 15.050 -1,07 560,38 -91.342 8.433.719
2020-04-20 2020-04-17 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -285 15.213 -1,84 559,79 -159.540 8.516.085
2020-04-20 2020-04-17 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -293 15.498 -1,86 558,55 -163.655 8.656.408
2020-04-20 2020-04-17 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -93 15.791 -0,59 557,40 -51.838 8.801.903
2020-04-20 2020-04-17 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -198 15.884 -1,23 556,51 -110.189 8.839.605
2020-04-20 2020-04-17 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -114 16.082 -0,70 555,10 -63.281 8.927.118
2020-04-20 2020-04-17 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -104 16.196 -0,64 552,85 -57.496 8.953.959
2020-04-20 2020-04-17 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -6 16.300 -0,04 550,00 -3.300 8.965.000
2020-04-20 2020-04-17 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -100 16.306 -0,61 549,24 -54.924 8.955.907
2020-04-20 2020-04-17 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -99 16.406 -0,60 548,27 -54.279 8.994.918
2020-04-20 2020-04-17 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -100 16.505 -0,60 547,00 -54.700 9.028.235
2020-04-20 2020-04-17 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -5 16.605 -0,03 542,31 -2.712 9.005.058
2020-04-20 2020-04-17 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -95 16.610 -0,57 541,94 -51.484 9.001.623
2020-04-20 2020-04-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes X -2.733 16.705 -14,06 529,79 -1.447.916 8.850.142
2020-04-20 2020-04-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 5.000 19.438 34,63 59,20 296.000 1.150.730
2020-04-16 2020-04-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -6 14.438 -0,04 525,30 -3.152 7.584.281
2020-04-16 2020-04-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -106 14.444 -0,73 524,99 -55.649 7.582.956
2020-04-16 2020-04-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -113 14.550 -0,77 521,05 -58.879 7.581.278
2020-04-16 2020-04-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -220 14.663 -1,48 520,45 -114.499 7.631.358
2020-04-16 2020-04-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -286 14.883 -1,89 519,43 -148.557 7.730.677
2020-04-16 2020-04-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -499 15.169 -3,18 518,25 -258.607 7.861.334
2020-04-16 2020-04-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -266 15.668 -1,67 517,40 -137.628 8.106.623
2020-04-16 2020-04-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -260 15.934 -1,61 516,81 -134.371 8.234.851
2020-04-16 2020-04-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -414 16.194 -2,49 515,70 -213.500 8.351.246
2020-04-16 2020-04-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -92 16.608 -0,55 514,63 -47.346 8.546.975
2020-04-16 2020-04-14 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
M - Exercise X -5.000 34.933 -12,52
2020-04-16 2020-04-14 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes X -2.738 16.700 -14,09 521,45 -1.427.730 8.708.215
2020-04-16 2020-04-14 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 5.000 19.438 34,63 59,20 296.000 1.150.730
2020-04-03 2020-04-02 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -100 14.438 -0,69 497,32 -49.732 7.180.306
2020-04-03 2020-04-02 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -210 14.538 -1,42 496,50 -104.265 7.218.117
2020-04-03 2020-04-02 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -321 14.748 -2,13 495,19 -158.956 7.303.062
2020-04-03 2020-04-02 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -111 15.069 -0,73 494,36 -54.874 7.449.511
2020-04-03 2020-04-02 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -652 15.180 -4,12 493,35 -321.664 7.489.053
2020-04-03 2020-04-02 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -521 15.832 -3,19 492,62 -256.655 7.799.160
2020-04-03 2020-04-02 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -450 16.353 -2,68 491,42 -221.139 8.036.191
2020-04-03 2020-04-02 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -484 16.803 -2,80 490,32 -237.315 8.238.847
2020-04-03 2020-04-02 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -734 17.287 -4,07 489,72 -359.454 8.465.790
2020-04-03 2020-04-02 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1.626 18.021 -8,28 488,26 -793.911 8.798.933
2020-04-03 2020-04-02 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -470 19.647 -2,34 487,71 -229.224 9.582.038
2020-04-03 2020-04-02 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -485 20.117 -2,35 486,61 -236.006 9.789.133
2020-04-03 2020-04-02 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -441 20.602 -2,10 485,65 -214.172 10.005.361
2020-04-03 2020-04-02 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -192 21.043 -0,90 484,58 -93.039 10.197.017
2020-04-03 2020-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
M - Exercise X -5.000 39.933 -11,13
2020-04-03 2020-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
M - Exercise X -5.000 39.933 -11,13
2020-04-03 2020-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
M - Exercise X -5.000 44.933 -10,01
2020-04-03 2020-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes X -2.689 21.235 -11,24 488,22 -1.312.824 10.367.352
2020-04-03 2020-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 5.000 23.924 26,42 59,20 296.000 1.416.301
2020-04-03 2020-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 5.000 23.924 26,42 59,20 296.000 1.416.301
2020-04-03 2020-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 5.000 23.924 26,42 59,20 296.000 1.416.301
2020-04-03 2020-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes X -2.757 18.924 -12,72 488,22 -1.346.023 9.239.075
2020-04-03 2020-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes X -2.757 18.924 -12,72 488,22 -1.346.023 9.239.075
2019-12-13 2019-12-11 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
A - Award 24.500 24.500
2019-12-13 2019-12-11 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
A - Award 2.625 14.438 22,22
2018-12-14 2018-12-12 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 20.000 20.000
2017-12-13 2017-12-12 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 23.337 23.337
2016-12-19 2016-12-16 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 24.565 24.565
2016-09-02 2016-09-01 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes -4.943 11.813 -29,50 392,63 -1.940.770 4.638.138
2015-12-18 2015-12-16 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 28.900 28.900
2015-09-02 2015-09-01 4 REGN REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise -1.689 0 -100,00
2015-09-02 2015-09-01 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise 1.689 16.756 11,21 59,20 99.989 991.955
2015-03-26 2015-03-25 4 REGN REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise -3.097 1.689 -64,71
2015-03-26 2015-03-25 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise 3.097 15.067 25,87 59,20 183.342 891.966
2015-03-17 2015-03-16 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -18.311 54.933 -25,00
2015-03-17 2015-03-16 4 REGN REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise -1.970 4.786 -29,16
2015-03-17 2015-03-16 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise 1.970 11.970 19,70 59,20 116.624 708.624
2015-03-17 2015-03-16 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -18.311 10.000 -64,68 450,00 -8.239.950 4.500.000
2015-03-17 2015-03-16 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise X 18.311 28.311 183,11 59,20 1.084.011 1.676.011
2014-12-18 2014-12-16 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 34.000 34.000
2014-12-18 2014-12-16 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 6.000 10.000 150,00
2013-12-17 2013-12-13 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 40.000 40.000
2012-12-17 2012-12-14 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 50.000 50.000
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)